SCHEMBL7338264

SCHEMBL7338264

Nc1cc2c([nH]c1=O)CCc1ccccc1-2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 3/20 0.46
CES1 P23141 1/20 0.44
PDE3B Q13370 2/20 0.44
PDE3A Q14432 2/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
SRD5A1 P18405 2/20 0.41
MAPK14 Q16539 3/20 0.40
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
PDPK1 O15530 1/20 0.39
PARP1 P09874 1/20 0.39
PARP10 Q53GL7 1/20 0.39
PARP11 Q9NR21 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SRD5A2 P31213 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7345733 0.91 CYP2A6 (0.46) TYMSCES1PDE3BPDE3APDE4A
SCHEMBL7347685 0.85 PDE3B (0.45) TYMSCES1PDE3BPDE3APDE4A
SCHEMBL7342347 0.81 CES1 (0.44) TYMSCES1SRD5A1PDPK1PARP1
SCHEMBL7336897 0.81 CES1 (0.44) TYMSCES1SRD5A1PDPK1PARP1
SCHEMBL7347975 0.80 TYMS (0.51) TYMSPDE3BPDE3APDE4APDE4B
SCHEMBL7339006 0.80 NOTUM (0.44) TYMSCES1SRD5A1PARP1SRD5A2
SCHEMBL7345932 0.79 CES1 (0.40) TYMSCES1SRD5A1PDPK1PARP1
SCHEMBL7342355 0.79 CES1 (0.40) TYMSCES1SRD5A1PDPK1PARP1
SCHEMBL7338490 0.79 AURKB (0.44) TYMSPDE3BPDE3APDE4APDE4B
SCHEMBL7340881 0.78 KDM4E (0.54) CES1SRD5A1SRD5A2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4511569-A Tricyclic lactams and derivatives useful in increasing cardiac contractility SCHERING CORPORATION (US) 1985-04-16 US disclosed